Stock Scorecard



Stock Summary for Alcon Inc (ALC) - $77.60 as of 1/5/2026 6:56:15 PM EST

Total Score

12 out of 30

Safety Score

62 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ALC

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ALC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ALC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ALC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ALC (62 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 4
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for ALC

Alcon Inc. Stock: Quiet Rally, Strong Vision – Is The Market Still Underestimating This Eye-Care G 1/4/2026 12:01:00 PM
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference 12/31/2025 1:09:00 AM
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference 12/30/2025 4:30:00 PM
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference 12/30/2025 4:30:00 PM
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference 12/30/2025 1:30:00 PM
Alcon Inc. stock: Quiet climb, sharper focus – is the market still underestimating this eye?care l 12/30/2025 6:09:00 AM
Big STAAR shareholder fights yet another delay on sale to Alcon 12/20/2025 5:08:00 AM
Eye implant maker delays shareholder vote on merger with Alcon 12/19/2025 5:08:00 PM
Alcon Exercises Right to Require STAAR Surgical to Delay Stockholder Meeting 12/19/2025 5:08:00 PM
Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon 12/19/2025 12:59:00 PM

Financial Details for ALC

Company Overview

Ticker ALC
Company Name Alcon Inc
Country USA
Description Alcon AG is a leading global eye care company headquartered in Geneva, Switzerland, dedicated to enhancing vision and improving eye health through innovative solutions. The company specializes in a comprehensive suite of ophthalmic products, including cutting-edge surgical equipment and vision care items, serving healthcare professionals and patients globally. Leveraging a strong focus on research and development alongside a robust product pipeline, Alcon is well-positioned to meet the increasing demand for eye care solutions driven by an aging population and the rising incidence of eye-related health issues. Its commitment to technological advancement underlines Alcon's status as a key player in the ophthalmic market, making it an attractive investment opportunity for institutional investors.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 9/30/2025
Next Earnings Date 2/24/2026

Stock Price History

Last Day Price 77.60
Price 4 Years Ago 67.65
Last Day Price Updated 1/5/2026 6:56:15 PM EST
Last Day Volume 1,419,525
Average Daily Volume 1,400,835
52-Week High 98.85
52-Week Low 71.55
Last Price to 52 Week Low 8.46%

Valuation Measures

Trailing PE 36.95
Industry PE 25.11
Sector PE 52.63
5-Year Average PE 32.41
Free Cash Flow Ratio 25.44
Industry Free Cash Flow Ratio 39.32
Sector Free Cash Flow Ratio 30.62
Current Ratio Most Recent Quarter 2.12
Total Cash Per Share 3.05
Book Value Per Share Most Recent Quarter 44.96
Price to Book Ratio 1.68
Industry Price to Book Ratio 2.89
Sector Price to Book Ratio 38.88
Price to Sales Ratio Twelve Trailing Months 3.76
Industry Price to Sales Ratio Twelve Trailing Months 3.33
Sector Price to Sales Ratio Twelve Trailing Months 11.30
Analyst Buy Ratings 15
Analyst Strong Buy Ratings 5

Share Statistics

Total Shares Outstanding 491,200,000
Market Capitalization 38,117,120,000
Institutional Ownership 68.26%

Dividends

Ex-Dividend Date 5/14/2025
Previous Dividend Amount 0.2400
Current Dividend Amount 0.2800
Total Years Dividend Increasing 5
Trailing Annual Dividend Rate 0.28
Trailing Annual Dividend Yield 0.36%
Forward Annual Dividend Rate 0.28
Forward Annual Dividend Yield 0.36%
5-Year Dividend Payments Count 5
3-Year Average Dividend Yield 0.30%
5-Year Average Dividend Yield 0.26%
1-Year Dividend Growth Rate Percentage 16.67%
3-Year Dividend Growth Rate Percentage 15.47%
5-Year Dividend Growth Rate Percentage 29.36%
All-Time Dividend Growth Rate Percentage 29.36%
Dividend Payout Ratio 13.33%

Income Statement

Quarterly Earnings Growth YOY -9.40%
Annual Earnings Growth 4.52%
Reported EPS 12 Trailing Months 2.10
Reported EPS Past Year 2.28
Reported EPS Prior Year 2.90
Net Income Twelve Trailing Months 1,047,000,000
Net Income Past Year 1,018,000,000
Net Income Prior Year 974,000,000
Quarterly Revenue Growth YOY 6.50%
5-Year Revenue Growth 5.71%
Operating Margin Twelve Trailing Months 12.90%

Balance Sheet

Total Cash Most Recent Quarter 1,496,409,985
Total Cash Past Year 1,676,000,000
Total Cash Prior Year 1,094,000,000
Net Cash Position Most Recent Quarter -3,167,590,015
Net Cash Position Past Year -2,862,000,000
Long Term Debt Past Year 4,538,000,000
Long Term Debt Prior Year 4,594,000,000
Total Debt Most Recent Quarter 4,664,000,000
Equity to Debt Ratio Past Year 0.83
Equity to Debt Ratio Most Recent Quarter 0.83
Total Stockholder Equity Past Year 21,553,000,000
Total Stockholder Equity Prior Year 20,624,000,000
Total Stockholder Equity Most Recent Quarter 22,062,557,367

Free Cash Flow

Free Cash Flow Twelve Trailing Months 1,532,870,614
Free Cash Flow Per Share Twelve Trailing Months 3.12
Free Cash Flow Past Year 1,407,000,000
Free Cash Flow Prior Year 537,000,000

Options

Put/Call Ratio 1.23
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.38
MACD Signal 0.64
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.69
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 1/5/2026 4:54:36 PM EST